Pharmaceutical companies would spend, on average, several billion dollars for every new therapeutic protein that is eventually commercialized. The underlying reason for this huge cost is the exceptionally high rate of failure observed in the development process: approximately 90% of drug candidates failed during clinical trials.
https://www.creative-biolabs.com/drug-discovery/therapeutics/developability-assessment-of-biopharmaceutical-candidates.htm
